Turning Point Therapeutics TPTX
$ 75.16
-0.13%
Quarterly report 2022-Q2
added 08-08-2022
Country |
USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Athena Maria Countouriotis |
Employees in the company |
130 |
Shares |
49.3 M |
Market Cap[1] |
$ 3.73 B |
EBITDA (LTM) |
$ -321 M |
P/E (LTM) |
-11.63 |
P/S (LTM) |
604.81 |
EPS (LTM) |
-6.46 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.